ddrg/super_eurlex huggingface dataset:
Official Journal of the European Union

Prior notification of a concentration

(Case M.9931 – Stirling Square Capital Partners/TA Associates/DOCU Nordic Group)

Candidate case for simplified procedure

(Text with EEA relevance)

(2020/C 283/05)

1. On 20 August 2020, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 ( 1 ) This notification concerns the following undertakings: — SSCP Fourth Fund (Jersey), managed by Stirling Square Capital Partners Jersey AIFM Limited (‘SSCP’, Jersey), — TA Associates Management L.P. (‘TA Associates’, US), — SSCP BYGG TopCo AB (‘DOCU Nordic Group’, Sweden), solely controlled by SSCP. SSCP Fourth Fund and TA Associates acquire within the meaning of Article 3(1)(b) and 3(4) of the Merger Regulation joint control of the whole of DOCU Nordic Group. The concentration is accomplished by way of purchase of shares.

2. The business activities of the undertakings concerned are: — SSCP Fourth Fund: investment fund that seeks to make, hold, monitor and realise controlling investments via management buy-outs, management buy-ins, growth capital and other private equity transactions throughout Europe, — TA Associates: private equity firm focused on targeted sectors within five industries – technology, healthcare, financial service, consumer and business services, — DOCU Nordic Group: provider of market data and market intelligence services to companies in the Nordic construction industry as well as the Nordic property and healthcare sectors.

3. On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

4. The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission. Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified: M.9931 – Stirling Square Capital Partners/TA Associates/DOCU Nordic Group Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below: Email: COMP-MERGER-REGISTRY@ec.europa.eu Fax +32 22964301 Postal address: European Commission Directorate-General for Competition Merger Registry 1049 Bruxelles/Brussel BELGIQUE/BELGIË

(1) OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

(2) OJ C 366, 14.12.2013, p. 5.
Official Journal of the European Union

Prior notification of a concentration

(Case M.9876 – TA Associates/Francisco Partners/Edifecs)

Candidate case for simplified procedure

(Text with EEA relevance)

(2020/C 278/04)

1. On 13 August 2020, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 ( 1 ) This notification concerns the following undertakings: — funds managed by TA Associates Management L.P. (‘TA Associates’, United States), — funds managed by Francisco Partners Management LP (‘Francisco Partners’, United States), — Edifecs, Inc. (‘Edifecs’, United States). TA Associates and Francisco Partners acquire within the meaning of Article 3(1)(b) of the Merger Regulation joint control over Edifecs. The concentration is accomplished by way of purchase of shares.

2. The business activities of the undertakings concerned are: — for TA Associates: private equity firm, active in investing in five core sectors, namely technology, financial services, healthcare, consumer and business services industries in Europe, North America and Asia, — for Francisco Partners: private equity firm exclusively focused on investment in technology and technology-enabled businesses, — for Edifecs: healthcare technology company active in the provision of infrastructure solutions which aim to improve operational performance by streamlining the exchange of information between hospitals and other healthcare organisations, while enabling compliance with industry regulations.

3. On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

4. The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission. Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified: M.9876 – TA Associates/Francisco Partners/Edifecs Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below: Email: COMP-MERGER-REGISTRY@ec.europa.eu Fax +32 22964301 Postal address: European Commission Directorate-General for Competition Merger Registry 1049 Bruxelles/Brussel BELGIQUE/BELGIË

(1) OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

(2) OJ C 366, 14.12.2013, p. 5.
Non-opposition to a notified concentration

(Case M.9918 – Cummins/ETC/NPROXX)

(Text with EEA relevance)

(2020/C 298/01)

On 31 August 2020, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

— in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

— in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32020M9918. EUR-Lex is the online access to European law.

(1) OJ L 24, 29.1.2004, p. 1.
Non-opposition to a notified concentration

(Case M.9877 – Pro Diagnostic Group/FutureLife/DISCARE CZ JV)

(Text with EEA relevance)

(2020/C 291/01)

On 27 August 2020, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

— in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

— in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32020M9877. EUR-Lex is the online access to European law.

(1) OJ L 24, 29.1.2004, p. 1.
Prior notification of a concentration

(Case M.9955 – PSP/Aviva/20 Station Road)

Candidate case for simplified procedure

(Text with EEA relevance)

(2020/C 316/10)

1. On 14 September 2020, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 ( 1 ) This notification concerns the following undertakings: — Public Sector Pension Investment Board (‘PSP’, Canada), — Aviva Plc Group (‘Aviva’, United Kingdom), — 20 Station Road (United Kingdom). PSP and Aviva acquire within the meaning of Article 3(1)(b) of the Merger Regulation control of the whole of 20 Station Road. The concentration is accomplished by way of purchase of assets.

2. The business activities of the undertakings concerned are: — for PSP: the pension investment manager of the pension plans of the Canadian Federal Public Service, the Canadian Forces, the Royal Canadian Mounted Police and the Reserve Force. It manages a diversified global portfolio including stocks, bonds and other fixed-income securities as well as investments in private equity, real estate, infrastructure, natural resources and credit investments, — for Aviva: a UK incorporated listed company operating in the insurance sector. Aviva Plc is listed on the main market of the London Stock Exchange. Aviva’s group provides a broad range of insurance, savings and investment products across 16 countries. Aviva’s group is principally active in the UK, France and Canada but also has operations elsewhere in Europe and Asia, — For 20 Station Road: a commercial real estate property situated on 20 Station Road in Cambridge, CB1, United Kingdom.

3. On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

4. The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission. Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified: M.9955 – PSP/Aviva/20 Station Road Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below: Email: COMP-MERGER-REGISTRY@ec.europa.eu Fax +32 22964301 Postal address: European Commission Directorate-General for Competition Merger Registry 1049 Bruxelles/Brussel BELGIQUE/BELGIË

(1) OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

(2) OJ C 366, 14.12.2013, p. 5.
Non-opposition to a notified concentration

(Case M.9908 – Bonduelle/Unibel/Sparkling Partners/Végéhub/Yumi)

(Text with EEA relevance)

(2020/C 307/01)

On 11 September 2020, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in French and will be made public after it is cleared of any business secrets it may contain. It will be available:

— in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes.

— in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32020M9908. EUR-Lex is the online access to European law.

(1) OJ L 24, 29.1.2004, p. 1.
Non-opposition to a notified concentration

(Case M.9910 — Mapfre Group/Santander Group/Popular Seguros JV)

(Text with EEA relevance)

(2020/C 325/02)

On 22 September 2020, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

— in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

— in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32020M9910. EUR-Lex is the on-line access to European law.

(1) OJ L 24, 29.1.2004, p. 1.
Official Journal of the European Union

Prior notification of a concentration

(Case M.9917 — Liberty/Ascoval/Hayange)

Candidate case for simplified procedure

(Text with EEA relevance)

(2020/C 321/04)

1. On 22 September 2020, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 ( 1 ) This notification concerns the following undertakings: — Liberty House Group PTE Ltd. (‘Liberty’, Singapore), belonging to the group Liberty Group, — France Rail Industry (‘FRI’, France), ultimately controlled by Greybull, — Ascoval Saint-Saulve (‘Ascoval’, France), ultimately controlled by Greybull. Liberty acquires within the meaning of Article 3(1)(b) of the Merger Regulation control of the whole of FRI and Ascoval. The concentration is accomplished by way of purchase of shares.

2. The business activities of the undertakings concerned are: — for Liberty: Liberty belongs to Liberty Group, an international metals and industrial group, specialising in commodities, metals recycling, manufacture of steel, aluminium and engineering products, — for FRI: FRI operates the Hayange steel factory located in France. Hayange produces rails, a type of finished steel products, — for Ascoval: Ascoval is a plant located in France which produces semi-finished steel products.

3. On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

4. The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission. Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified: M.9917 — Liberty/Ascoval/Hayange Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below: Email: COMP-MERGER-REGISTRY@ec.europa.eu Fax +32 22964301 Postal address: European Commission Directorate-General for Competition Merger Registry 1049 Bruxelles/Brussel BELGIQUE/BELGIË

(1) OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

(2) OJ C 366, 14.12.2013, p. 5.
Non-opposition to a notified concentration

(Case M.9379 — Umicore/Cattierite Holdings Coöperatief)

(Text with EEA relevance)

(2020/C 335/02)

On 25 November 2019, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

— in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

— in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32019M9379. EUR-Lex is the on-line access to European law.

(1) OJ L 24, 29.1.2004, p. 1.
Prior notification of a concentration

(Case M.9871 — Telefónica/Liberty Global/JV)

(Text with EEA relevance)

(2020/C 330/06)

1. On 30 September 2020, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 ( 1 ) This notification concerns the following undertakings: — Telefónica S.A. (‘Telefónica’, Spain), — Liberty Global PLC (‘Liberty Global’, UK), — the Joint Ventre (‘JV’, UK). Telefónica and Liberty Global acquire within the meaning of Article 3(1)(b) and 3(4) of the Merger Regulation joint control of the newly created JV, combining Telefónica’s UK Limited business (‘O2’) and Liberty Global’s Virgin Media business (‘Virgin Media’). The concentration is accomplished by way of a purchase of shares in a newly created company constituting a joint venture.

2. The business activities of the undertakings concerned are: — for Telefónica: global telecommunications company which operates fixed and mobile communication networks. It offers mobile, landline, internet and television services under a number of brands, including Movistar, O2 and Vivo. Telefónica is listed on the Madrid, New York, Lima and Buenos Aires Stock Exchanges. Telefónica’s O2 business is active in the UK and offers mobile telecommunications services, such as voice, SMS, MMS, mobile internet, mobile broadband, roaming and call termination services. — for Liberty Global: an international video, broadband and communications company listed on the NASDAQ stock exchange, with consolidated operations in the UK, Ireland, Belgium, Poland and Slovakia. Liberty Global’s Virgin Media business is active in the UK and its principal activity is the provision of fixed-line broadband, telephony and pay-TV services. Virgin Media also provides mobile communications services as an MVNO under the Virgin Mobile brand. — for the JV: a fixed and mobile communications network operator active in the UK, combining Telefónica’s O2 business and Liberty Global’s Virgin Media business. This also includes O2’s interests in the Tesco Mobile joint venture, which is active as a mobile virtual network operator (‘MVNO’) in the UK, and the CTIL mobile network-sharing joint venture with Vodafone.

3. On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved.

4. The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission. Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified: M.9871 — Telefónica/Liberty Global/JV Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below: Email: COMP-MERGER-REGISTRY@ec.europa.eu Fax +32 22964301 Postal address: European Commission Directorate-General for Competition Merger Registry 1049 Bruxelles/Brussel BELGIQUE/BELGIË

(1) OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).
Non-opposition to a notified concentration

(Case M.9303 — LetterOne/DIA)

(Text with EEA relevance)

(2020/C 344/04)

On 12 March 2019, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

— in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

— in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32019M9303. EUR-Lex is the on-line access to European law.

(1) OJ L 24, 29.1.2004, p. 1.
Official Journal of the European Union

Prior notification of a concentration

(Case M.9861 — Unilabs/Medbase/JV)

Candidate case for simplified procedure

(Text with EEA relevance)

(2020/C 342/06)

1. On 6 October 2020, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 ( 1 ) This notification concerns the following undertakings: — Unilabs Holding AB (“Unilabs”, Sweden), — Medbase AG (“Medbase”, Switzerland) Unilabs and Medbase acquire within the meaning of Article 3(1)(b) and 3(4) of the Merger Regulation joint control of a newly created company constituting a joint venture (“the JV”). The concentration is accomplished by way of purchase of shares.

2. The business activities of the undertakings concerned are: — for Unilabs: provision of bio-medical testing services, medical imaging services, reproductive medicine services and drug development services in a number of European countries, — for Medbase: provision of medical and therapeutic services exclusively in Switzerland, — the JV: provision of medical laboratory diagnostics services exclusively in Switzerland and predominantly in Eastern Switzerland.

3. On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

4. The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission. Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified: M.9861 — Unilabs/Medbase/JV Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below: Email: COMP-MERGER-REGISTRY@ec.europa.eu Fax +32 22964301 Postal address: European Commission Directorate-General for Competition Merger Registry 1049 Bruxelles/Brussel BELGIQUE/BELGIË

(1) OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

(2) OJ C 366, 14.12.2013, p. 5.
Non-opposition to a notified concentration

(Case M.9941 — Private Theory Luxco/ARC Group)

(Text with EEA relevance)

(2020/C 351/04)

On 15 October 2020, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

— in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

— in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32020M9941. EUR-Lex is the on-line access to European law.

(1) OJ L 24, 29.1.2004, p. 1.